TARS
Tarsus Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $3.08B | Price | $68.81 |
| Volume | 524.00K | Change | -0.22% |
| P/E Ratio | -26.6 | Open | $68.72 |
| Revenue | $183.0M | Prev Close | $68.96 |
| Net Income | $-115.6M | 52W Range | $38.51 - $76.81 |
| Div Yield | N/A | Target | $79.43 |
| Overall | 55 | Value | 40 |
| Quality | 47 | Technical | 80 |
No chart data available
Stock Overview
Updated DailyTarsus Pharmaceuticals Inc. (TARS) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $68.81 with a market capitalization of $3.08 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows TARS with a volume of 524K shares. The stock opened down 0.35% from yesterday's close of $68.96. Current analyst estimates project earnings of $-1.62 per share for this year, with next year targeting $1.16.
TARS demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for TARS include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 15.4%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 03:10 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TARS | $68.81 | -0.2% | 524.00K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tarsus Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW